Hyper-beta-alaninemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309147OMIM:237400E79.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hyper-beta-alaninemia is an extremely rare inherited metabolic disorder in which the body cannot properly break down beta-alanine, a naturally occurring amino acid. This leads to a buildup of beta-alanine and related compounds (such as beta-aminoisobutyric acid and gamma-aminobutyric acid, also known as GABA) in the blood and urine. The condition is caused by a deficiency of the enzyme beta-alanine-alpha-ketoglutarate aminotransferase, which is responsible for metabolizing beta-alanine. Symptoms typically appear in infancy or early childhood and primarily affect the nervous system. Children with this condition may experience seizures, excessive sleepiness or lethargy, and developmental delays. Because GABA is an important brain chemical involved in calming nerve activity, its abnormal accumulation may contribute to the neurological problems seen in this disorder. Hyper-beta-alaninemia is so rare that only a handful of cases have been described in the medical literature. There is currently no cure for this condition. Treatment is supportive and focuses on managing seizures and supporting development through therapies. Because so few patients have been identified, the full range of symptoms and long-term outcomes are not well understood. Early diagnosis and management by a team of metabolic and neurological specialists is important to optimize quality of life.

Also known as:

Key symptoms:

SeizuresExcessive sleepiness or lethargyDevelopmental delayLow muscle tone (floppiness)Difficulty feeding in infancyIntellectual disabilityElevated beta-alanine levels in blood and urineBreathing difficulties in severe cases

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hyper-beta-alaninemia.

View clinical trials →

No actively recruiting trials found for Hyper-beta-alaninemia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hyper-beta-alaninemia community →

No specialists are currently listed for Hyper-beta-alaninemia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hyper-beta-alaninemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hyper-beta-alaninemiaForum →

No community posts yet. Be the first to share your experience with Hyper-beta-alaninemia.

Start the conversation →

Latest news about Hyper-beta-alaninemia

No recent news articles for Hyper-beta-alaninemia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific tests confirmed the diagnosis, and should any family members be tested?,What seizure medications are recommended, and what side effects should I watch for?,Are there any dietary changes that could help manage my child's condition?,What developmental therapies should we start, and how often?,How will you monitor my child's amino acid levels over time?,Are there any research studies or clinical trials we should know about?,What emergency plan should we have in place for seizures?

Common questions about Hyper-beta-alaninemia

What is Hyper-beta-alaninemia?

Hyper-beta-alaninemia is an extremely rare inherited metabolic disorder in which the body cannot properly break down beta-alanine, a naturally occurring amino acid. This leads to a buildup of beta-alanine and related compounds (such as beta-aminoisobutyric acid and gamma-aminobutyric acid, also known as GABA) in the blood and urine. The condition is caused by a deficiency of the enzyme beta-alanine-alpha-ketoglutarate aminotransferase, which is responsible for metabolizing beta-alanine. Symptoms typically appear in infancy or early childhood and primarily affect the nervous system. Children w

How is Hyper-beta-alaninemia inherited?

Hyper-beta-alaninemia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hyper-beta-alaninemia typically begin?

Typical onset of Hyper-beta-alaninemia is infantile. Age of onset can vary across affected individuals.